Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BEXAR COUNTY HOSPITAL DISTRICT

NPI: 1306973789 · SAN ANTONIO, TX 78221 · Ambulatory Family Planning Facility · NPI assigned 02/27/2007

$260K
Total Medicaid Paid
10,285
Total Claims
9,818
Beneficiaries
30
Codes Billed
2020-07
First Month
2024-09
Last Month

Provider Details

Authorized OfficialDEMING, PEGGY (CFO)
Parent OrganizationBEXAR COUNTY HOSPITAL DISTRICT
NPI Enumeration Date02/27/2007

Related Entities

Other providers sharing the same authorized official: DEMING, PEGGY

ProviderCityStateTotal Paid
BEXAR COUNTY HOSPITAL DISTRICT SAN ANTONIO TX $339K
BEXAR COUNTY HOSPITAL DISTRICT SAN ANTONIO TX $203K
BEXAR COUNTY HOSPITAL DISTRICT - EASTSIDE SAN ANTONIO TX $140K
BEXAR COUNTY HOSPITAL DISTRICT SAN ANTONIO TX $136K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 2,599 $32K
2021 3,277 $80K
2022 1,864 $69K
2023 1,636 $51K
2024 909 $29K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
81513 412 406 $48K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,250 1,223 $36K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,250 1,223 $36K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 566 478 $30K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 985 856 $24K
J1050 Injection, medroxyprogesterone acetate, 1 mg 239 239 $18K
S4993 Contraceptive pills for birth control 261 257 $17K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 412 406 $12K
87800 254 250 $9K
88142 463 458 $8K
84703 1,069 1,033 $7K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 150 148 $6K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 264 260 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 107 107 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 55 55 $2K
86780 112 111 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 86 58 $1K
81003 180 173 $339.93
90686 13 13 $239.85
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 41 41 $219.52
3008F 398 377 $0.00
3044F 76 66 $0.00
1000F 289 275 $0.00
3079F 12 12 $0.00
3074F 275 264 $0.00
1036F 165 154 $0.00
3075F 38 38 $0.00
87481 316 313 $0.00
1160F 241 232 $0.00
3078F 306 292 $0.00